{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T14:46:19Z","timestamp":1744987579510},"reference-count":22,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/etm.2017.4309","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T08:10:07Z","timestamp":1491379807000},"page":"3097-3102","source":"Crossref","is-referenced-by-count":4,"title":["GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles"],"prefix":"10.3892","volume":"13","author":[{"given":"Xiang-Hong","family":"Zhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,5]]},"reference":[{"key":"key20180108134801_b1-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"key20180108134801_b2-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","article-title":"GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome and risk of ovarian hyperstimulation: A meta-analysis","volume":"13","author":"Griesinger","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key20180108134801_b3-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.fertnstert.2007.10.042","article-title":"Mitochondrial distribtuion and activity in human mature oocytes: Gonadotropin-releasing hormone agonist versus antagonist for pituitary down-regulation","volume":"91","author":"Dell'Aquila","year":"2009","journal-title":"Fertil Steril"},{"key":"key20180108134801_b4-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/oxfordjournals.humrep.a135991","article-title":"In vitro fertilization in completely natural cycles","volume":"10","author":"Fahy","year":"1995","journal-title":"Hum Reprod"},{"key":"key20180108134801_b5-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0140-6736(01)06797-6","article-title":"Gonadotrophin-releasing hormone receptor antagonists","volume":"358","author":"Huirne","year":"2001","journal-title":"Lancet"},{"key":"key20180108134801_b6-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/humrep\/deh613","article-title":"Can we eliminate severe ovarian hyperstimulation syndrome?","volume":"20","author":"Orvieto","year":"2005","journal-title":"Hum Reprod"},{"key":"key20180108134801_b7-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/dmp048","article-title":"World health organization reference values for human semen characteristics","volume":"16","author":"Cooper","year":"2010","journal-title":"Hum Reprod Update"},{"key":"key20180108134801_b8-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key20180108134801_b9-etm-0-0-4309","first-page":"CD001750","article-title":"Gonadotrophin- releasing hormone antagonists for assisted reproductive technology","volume":"11","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key20180108134801_b10-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/09513590.2012.736561","article-title":"Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: A systematic review and meta analysis","volume":"29","author":"Xiao","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl 4","key":"key20180108134801_b11-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"S1466","DOI":"10.1016\/j.fertnstert.2008.07.1711","article-title":"What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?","volume":"91","author":"Orvieto","year":"2009","journal-title":"Fertil Steril"},{"key":"key20180108134801_b12-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Gonadotrophin releasing hormone antagonists for assisted conception: A Cochrane review","volume":"14","author":"Al-Inany","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"key20180108134801_b13-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.fertnstert.2008.02.165","article-title":"Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40","volume":"91","author":"Sbracia","year":"2009","journal-title":"Fertil Steril"},{"key":"key20180108134801_b14-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/humupd\/dmr004","article-title":"GnRH antagonists are safer than agonists: An update of a Cochrane review","volume":"17","author":"Al-Inany","year":"2011","journal-title":"Hum Reprod Update"},{"key":"key20180108134801_b15-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0378(98)00019-9","article-title":"The hormonal control of endometrial receptivity: Estrogen (E2) and progesterone","volume":"39","author":"de Ziegler","year":"1998","journal-title":"J Reprod Immunol"},{"key":"key20180108134801_b16-etm-0-0-4309","first-page":"834","article-title":"Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation","volume":"87","author":"Kdous","year":"2009","journal-title":"Tunis Med"},{"key":"key20180108134801_b17-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10815-011-9570-4","article-title":"Different ART outcomes at increasing peak estradiol levels with long and antagonist protocols: Retrospective insights from ten years experience","volume":"28","author":"Manno","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"key20180108134801_b18-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"e106854","DOI":"10.1371\/journal.pone.0106854","article-title":"Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: A systematic review and meta-analysis","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"key":"key20180108134801_b19-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humupd\/2.4.323","article-title":"The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: A critical review","volume":"2","author":"Friedler","year":"1996","journal-title":"Hum Reprod Update"},{"key":"key20180108134801_b20-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0897.2009.00792.x","article-title":"Inflammation and implantation","volume":"63","author":"Dekel","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"key20180108134801_b21-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-12-96","article-title":"Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration","volume":"12","author":"Wu","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"key20180108134801_b22-etm-0-0-4309","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/B:JARG.0000043701.22835.56","article-title":"Significance of increased endometrial thickness in assisted reproduction technology treatments","volume":"21","author":"Yoeli","year":"2004","journal-title":"J Assist Reprod Genet"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2017.4309\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T19:15:40Z","timestamp":1515438940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.4309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,5]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,5]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/etm.2017.4309"],"URL":"https:\/\/doi.org\/10.3892\/etm.2017.4309","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,5]]}}}